Table 1.

Clinical characteristics of 10 patients with polymyalgia rheumatica (PMR)

Age	Gender	Symptom duration (months)	WBC (/mm3)	CRP (mg/dl)	ESR (mm/h)	PSL dose (mg)
69	F	1	7,690	1.18	85	5
82	F	2	9,520	15.35	87	5
76	M	3	5,030	5.1	85	10
58	F	4	6,100	10.3	98	15
68	M	1	5,550	3.53	84	15
70	F	5	8,210	4.89	79	5
58	F	1	10,870	5.95	94	10
73	F	2	6,180	8.66	94	10
75	F	1	6,010	4.15	91	15
67	M	2	6,840	0.67	56	15

PSL predonisolone